Lazard Asset Management LLC Sells 20,229 Shares of Guardian Pharmacy Services, Inc. $GRDN

Lazard Asset Management LLC lowered its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 12.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 147,502 shares of the company’s stock after selling 20,229 shares during the period. Lazard Asset Management LLC owned 0.30% of Guardian Pharmacy Services worth $5,555,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Boston Partners lifted its stake in Guardian Pharmacy Services by 418.7% in the 3rd quarter. Boston Partners now owns 1,046,877 shares of the company’s stock worth $26,922,000 after purchasing an additional 845,048 shares in the last quarter. Jennison Associates LLC grew its position in shares of Guardian Pharmacy Services by 609.5% during the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after purchasing an additional 706,823 shares in the last quarter. Loomis Sayles & Co. L P purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at $19,126,000. Millennium Management LLC increased its holdings in shares of Guardian Pharmacy Services by 725.2% in the third quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock worth $8,972,000 after purchasing an additional 300,587 shares during the period. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Guardian Pharmacy Services by 21.9% in the fourth quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock worth $31,538,000 after purchasing an additional 187,963 shares during the period.

Guardian Pharmacy Services Stock Performance

NYSE GRDN opened at $41.20 on Friday. Guardian Pharmacy Services, Inc. has a 52-week low of $19.30 and a 52-week high of $44.00. The company has a market capitalization of $2.05 billion, a P/E ratio of 49.64, a P/E/G ratio of 2.69 and a beta of 0.05. The company has a fifty day moving average of $40.70 and a 200-day moving average of $36.69.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating analysts’ consensus estimates of $0.24 by $0.05. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The business had revenue of $336.60 million for the quarter, compared to analysts’ expectations of $329.89 million. During the same quarter in the prior year, the firm earned $0.22 earnings per share. The firm’s revenue was up 2.2% on a year-over-year basis. As a group, analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

GRDN has been the subject of several research analyst reports. Bank of America lifted their price objective on Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Truist Financial upped their target price on Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Zacks Research cut Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a report on Monday, May 11th. Weiss Ratings downgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Finally, Oppenheimer lifted their price target on Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $42.83.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.